Sim1811-03 (Sim0235), An Anti-Tumor Necrosis Factor Receptor-2 (Tnfr2) Monoclonal Antibody, In Patients With Advanced Solid Tumor And/Or Cutaneous T Cell Lymphomas (Ctcl): Preliminary Results From An On-Going First-In-Human Phase I Trial In China
SIM1811-03
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Sim1811-03 (Sim0235), An Anti-Tumor Necrosis Factor Receptor-2 (Tnfr2) Monoclonal Antibody, In Patients With Advanced Solid Tumor And/Or Cutaneous T Cell Lymphomas (Ctcl): Preliminary Results From An On-Going First-In-Human Phase I Trial In China ### Output: SIM1811-03